These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30345329)

  • 1. The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD.
    Samaraweera APR; Falah Y; Pitiot A; Dineen RA; Morgan PS; Evangelou N
    Neurol Neuroimmunol Neuroinflamm; 2018 Nov; 5(6):e496. PubMed ID: 30345329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.
    Samaraweera AP; Clarke MA; Whitehead A; Falah Y; Driver ID; Dineen RA; Morgan PS; Evangelou N
    J Neuroimaging; 2017 Jan; 27(1):114-121. PubMed ID: 27300318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis?
    Lummel N; Boeckh-Behrens T; Schoepf V; Burke M; Brückmann H; Linn J
    Neuroradiology; 2011 May; 53(5):311-7. PubMed ID: 20585764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?
    Campion T; Smith RJP; Altmann DR; Brito GC; Turner BP; Evanson J; George IC; Sati P; Reich DS; Miquel ME; Schmierer K
    Eur Radiol; 2017 Oct; 27(10):4257-4263. PubMed ID: 28409356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
    Suhy J; Rooney WD; Goodkin DE; Capizzano AA; Soher BJ; Maudsley AA; Waubant E; Andersson PB; Weiner MW
    Mult Scler; 2000 Jun; 6(3):148-55. PubMed ID: 10871825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative clinical and neuroimaging features of motor-predominant hereditary diffuse leukoencephalopathy with axonal spheroids and primary progressive multiple sclerosis: A preliminary cross-sectional study.
    Saitoh BY; Yamasaki R; Hiwatashi A; Matsushita T; Hayashi S; Mitsunaga Y; Maeda Y; Isobe N; Yoshida K; Ikeda SI; Kira JI
    Mult Scler Relat Disord; 2019 Jun; 31():22-31. PubMed ID: 30901701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis by phenotype in Germany.
    Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
    Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
    Kau T; Taschwer M; Deutschmann H; Schönfelder M; Weber JR; Hausegger KA
    Eur Radiol; 2013 Jul; 23(7):1956-62. PubMed ID: 23436147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
    Sinnecker T; Clarke MA; Meier D; Enzinger C; Calabrese M; De Stefano N; Pitiot A; Giorgio A; Schoonheim MM; Paul F; Pawlak MA; Schmidt R; Kappos L; Montalban X; Rovira À; Evangelou N; Wuerfel J;
    JAMA Neurol; 2019 Dec; 76(12):1446-1456. PubMed ID: 31424490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central vein sign: comparison of multiple sclerosis and leukoaraiosis.
    Yavaş HG; Sağtaş E
    Turk J Med Sci; 2022 Dec; 52(6):1933-1942. PubMed ID: 36945994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI.
    Yiannakas MC; Tozer DJ; Schmierer K; Chard DT; Anderson VM; Altmann DR; Miller DH; Wheeler-Kingshott CA
    Mult Scler; 2013 May; 19(6):732-41. PubMed ID: 23037551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.
    Luo J; Yablonskiy DA; Hildebolt CF; Lancia S; Cross AH
    Mult Scler; 2014 Mar; 20(3):349-55. PubMed ID: 23836876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities.
    Lapucci C; Tazza F; Rebella S; Boffa G; Sbragia E; Bruschi N; Mancuso E; Mavilio N; Signori A; Roccatagliata L; Cellerino M; Schiavi S; Inglese M
    Front Neurol; 2023; 14():1084661. PubMed ID: 36970546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
    Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z
    Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Neuroimaging Marker Based on Diffusion Tensor Imaging and Cognitive Impairment Due to Cerebral White Matter Lesions.
    Wei N; Deng Y; Yao L; Jia W; Wang J; Shi Q; Chen H; Pan Y; Yan H; Zhang Y; Wang Y
    Front Neurol; 2019; 10():81. PubMed ID: 30814973
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
    Rahimian N; Saligheh Rad H; Firouznia K; Ebrahimzadeh SA; Meysamie A; Vafaiean H; Harirchian MH
    Iran J Radiol; 2013 Sep; 10(3):128-32. PubMed ID: 24348597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
    Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
    Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.